Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies-Reference-Cited by-同舟云学术

Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies

Published:2009-12 Issue:12 Volume:63 Page:1743-1761
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:

Author:

Bushe C. J.,Bradley A. J.,Doshi S.,Karagianis J.

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1742-1241.2009.02224.x/fullpdf

Reference63 articles.

1. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetologia,2006

2. A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies;Barnett;Curr Med Res Opin,2007

3. A well-being programme in severe mental illness. Baseline findings in a UK cohort;Smith;Int J Clin Pract,2007

4. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia;Lieberman;N Engl J Med,2005

5. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia;Barnett;J Psychopharmacol,2007

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of antipsychotic-induced hyperprolactinemia: an umbrella review of systematic reviews and meta-analyses;Frontiers in Psychiatry;2024-03-05

2. Treatment of antipsychotic-induced hyperprolactinemia: a systematic review of systematic reviews and meta-analyses;2023-08-17

3. Metabolic complications of glucocorticoids – Prevention by metformin;Annales d'Endocrinologie;2023-08

4. Pharmacotherapy of Obesity and Metabolic Syndrome;Metabolic Syndrome;2023

5. Pharmacotherapy of Obesity and Metabolic Syndrome;Metabolic Syndrome;2023